TP53 and cancer: Through whole-genome sequencing (WGS), it was assessed that EAC occurrence is most likely related to early mutations of TP53 gene, even in non-dysplastic BE, followed by genomic duplication driving the late stages of the cancer cascade, as confirmed by exome sequencing (34).